Douglas Janzen

Douglas Janzen

Chief Executive Officer at AEQUUS PHARMACEUTICALS INC.

Net worth: 12 554 $ as of 2026-06-29

58 year
Health Technology
Finance
Commercial Services

Profile

Douglas Glen Janzen is the founder of Aequus Pharmaceuticals, Inc., founded in 2013, serving as Chairman, President & Chief Executive Officer.
Mr. Janzen is the founder of Northview LifeSciences, founded in 2014.
Mr. Janzen is the founder of Northview Ventures & Associates General Partnership, founded in 2014, serving as Managing Director.
Current jobs include Chairman at Lexington Biosciences Holdings Corp.
since 2017, Director & Managing Director at LifeSciences British Columbia since 2010, Director at Synaptive Technologies Ltd., Director at Transdermal Research Pharm Laboratories LLC since 2013, and Director at Alabaster Technologies, Inc. Former jobs include President, Chief Executive Officer & Director at Correvio Pharma Corp.
from 2010 to 2012, Chairman at AbCellera Biologics, Inc., Chairman at Lexington Biosciences, Inc. from 2016 to 2021, Chairman at Perimeter Medical Imaging, Inc., Director at Medical Ventures Corp., Director at Teal Valley Health, Inc., Director at Aptamera, Inc., Director at Synaptive Medical, Inc., Director at BIOTECanada, Independent Director at iCo Therapeutics, Inc. from 2012 to 2015, Director at Sentinelle Medical ULC, Independent Director at Neovasc, Inc., Director at BioHEP Technologies Ltd., Director at Renaissance BioScience Corp., Director at AmpHP, Inc., Director at Perimeter Medical Imaging AI, Inc., Analyst at Cormark Securities, Inc. in 2002, President & Chief Business Officer at Bradmer Pharmaceuticals, Inc. from 2006 to 2007, and Head of Research at Loewen, Ondaatje, McCutcheon Ltd. in 2001.
Education includes graduate degree from the University of British Columbia and undergraduate degree from the University of Saskatchewan.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-09-23 12,553,800 ( 9.46% ) 12 554 $ 2026-06-29

Douglas Janzen active positions

CompaniesPositionStart
AEQUUS PHARMACEUTICALS INC. Chief Executive Officer 2013-01-02
Founder 2014-03-31
Alabaster Technologies, Inc.
Director/Board Member -
Chairman 2017-05-22
Director/Board Member 2013-03-02
Synaptive Technologies Ltd.
Director/Board Member -
Director/Board Member -
Founder 2014-03-31

Former positions of Douglas Janzen

CompaniesPositionEnd
REGISTERED PLAN PRIVATE INVESTMENTS INC. Chairman 2021-11-30
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Douglas Janzen's experience

Training of Douglas Janzen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

50

1st degree connections

29

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies29

Finance

Health Technology

Electronic Technology

Technology Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Synaptive Technologies Ltd.

Commercial Services

Health Technology

Alabaster Technologies, Inc.

Health Technology

Health Technology

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Douglas Janzen